Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology

Monocytes Promote cHSPC Expansion via MIF-CXCR4-ATP6V1A Axis

November 14, 2026 Dr. Michael Lee – Health Editor Health

Human circulating hematopoietic stem and progenitor cells in steady-state blood expand through an MIF-dependent mechanism.

Key Clinical Takeaways:

  • Monocytes most effectively promote circulating hematopoietic stem and progenitor cell expansion while preserving long-term reconstitution.
  • Cells engage the MIF-(CXCR4_CD74)-ATP6V1A axis to enhance endocytosis, lysosomal acidification, and glycolytic activity.
  • Monocyte co-culture and pathway agonists successfully expanded stem and progenitor cells from cord blood, bone marrow, and patient samples.

Stem Cell Expansion Limitations

Steady-state human circulating hematopoietic stem and progenitor cells remain a rare and underutilized resource for clinical transplantation. Poor ex vivo expansion capacity and unclear regulatory pathways have previously limited their use in therapies.

Immune Cell Screening Platform

Researchers utilized an immune-cell screening platform to identify which cell types best support stem cell growth. The screening revealed that monocytes promote hematopoietic stem and progenitor cell expansion most effectively. This co-culture approach preserves long-term hematopoietic reconstitution during serial transplantation.

Stem Cells Engage the MIF-(CXCR4_CD74)-ATP6V1A Axis to Maintain Stemness

Mechanistically, circulating stem and progenitor cells engage the MIF-(CXCR4_CD74)-ATP6V1A axis. This engagement enhances endocytosis and lysosomal acidification. The process subsequently upregulates CD34+CXCR4+ cells, reduces reactive oxygen species, stabilizes HIF-1α, and maintains both glycolytic activity and stemness.

Universal Expansion Strategy

Monocyte co-culture or specific pathway agonists—including MIF and EN6—successfully expanded stem and progenitor cells from diverse sources. These sources include steady-state peripheral blood, cord blood, bone marrow, and poor-graft-function patient samples. The mechanism provides a universal expansion strategy for functionally compromised hematopoietic cells.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

More on this story: New tRNA Mechanism Identified as Driver of Treatment Resistance in Advanced Prostate Cancer

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

More on this

  • US Loses Measles Elimination Status After 25 Years
  • CHLA’s Dr. Jesse Levine Explores Pediatric Neuroinflammatory Diseases

Related

general, Life Sciences

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service